UBS Reiterates Rating on BWIN $BWIN
Key Points
- UBS now rates The Baldwin Insurance Group, Inc. ($BWIN) "buy" with a $35.00 target.
- The Street's average $BWIN price target is $29.00 (Buy).
- $BWIN last traded around $18.61.
UBS reiterated its rating on The Baldwin Insurance Group, Inc. ($BWIN) to a "buy" rating, with a price target of $35.00 in a recent research note.
The Baldwin Insurance Group, Inc. ($BWIN) Stock
The Baldwin Insurance Group, Inc. Earnings
Analysts Set New Price Targets
About The Baldwin Insurance Group, Inc.
The Baldwin Insurance Group, Inc. operates as an independent insurance distribution firm that delivers insurance and risk management solutions in the United States. The company operates through three segments: Insurance Advisory Solutions; Underwriting, Capacity & Technology Solutions; and Mainstreet Insurance Solutions. Its Insurance Advisory Solutions segment provides private risk management, commercial risk management, employee benefits, and Medicare insurance solutions for businesses and high-net-worth individuals, as well as their families. The Underwriting, Capacity & Technology Solutions segment offers MGA platform, that manufactures technology-enabled insurance product suite comprises personal, commercial, and professional lines. Its Mainstreet Insurance Solutions segment provides personal insurance, commercial insurance, and life and health solutions to individuals and businesses in communities, as well as offers reinsurance brokerage; and consultation for government assistance programs and solutions, including traditional Medicare and Medicare advantage and affordable care act to seniors and eligible individuals through a network of primarily independent contractor agents. The company was formerly known as BRP Group, Inc. and changed its name to The Baldwin Insurance Group, Inc. in May 2024. The Baldwin Insurance Group, Inc. was founded in 2011 and is headquartered in Tampa, Florida.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.